Abiomed
ABMD
#1112
Rank
S$23.06 B
Marketcap
$511.42
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : S$0.21 Billion

According to Abiomed's latest financial reports the company's total liabilities are S$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31S$0.23 B3.69%
2021-03-31S$0.22 B3.19%
2020-03-31S$0.21 B35.05%
2019-03-31S$0.15 B25.43%
2018-03-31S$0.12 B-7.64%
2017-03-31S$0.13 B84.38%
2016-03-31S$74.52 M15.72%
2015-03-31S$64.39 M38%
2014-03-31S$46.66 M14.26%
2013-03-31S$40.83 M17.68%
2012-03-31S$34.7 M2.51%
2011-03-31S$33.85 M11.93%
2010-03-31S$30.24 M-0.49%
2009-03-31S$30.39 M-9.75%
2008-03-31S$33.67 M57.57%
2007-03-31S$21.37 M46.19%
2006-03-31S$14.61 M81.48%
2005-03-31S$8.05 M-0.28%
2004-03-31S$8.07 M-26.77%
2003-03-31S$11.03 M-41.42%
2002-03-31S$18.83 M11.12%
2001-03-31S$16.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$4.03 B 1,816.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.98 B 10,822.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.20 B-4.28%๐Ÿ‡บ๐Ÿ‡ธ USA